Home › Stocks › AVIR › All Fund Holders
AVIR — ATEA PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 42 · Reported value held: $228.23M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Viking Global Investors history | Q3 2021 | 1.66M | $58.03M | 0.18% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 12.00M | $55.82M | 0.00% | Hold |
| BlackRock Inc history | Q2 2026 | 8.72M | $40.55M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 4.23M | $15.09M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 1.96M | $9.11M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 1.51M | $7.01M | 0.01% | Reduce |
| Renaissance Technologies history | Q2 2026 | 1.13M | $5.26M | 0.01% | Reduce |
| CPP Investments history | Q3 2021 | 138.00K | $4.84M | 0.01% | New |
| JPMorgan Chase & Co history | Q2 2026 | 945.92K | $4.36M | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 755.24K | $3.51M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 719.51K | $3.35M | 0.00% | Reduce |
| Moore Capital Management history | Q3 2021 | 88.70K | $3.11M | 0.05% | New |
| Charles Schwab Investment Management history | Q2 2026 | 610.61K | $2.84M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 530.86K | $2.47M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 345.19K | $1.61M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 304.61K | $1.42M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 267.12K | $1.24M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 247.71K | $1.15M | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 210.54K | $979.02K | 0.00% | Hold |
| Wellington Management Group history | Q2 2026 | 206.78K | $961.55K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 189.45K | $880.95K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 157.22K | $731.09K | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 119.55K | $643.20K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 94.51K | $439.46K | 0.00% | Reduce |
| Marshall Wace history | Q4 2025 | 113.58K | $405.50K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 81.73K | $380.04K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 70.40K | $327.36K | 0.00% | Add |
| MFS Investment Management history | Q3 2022 | 51.14K | $291.00K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 59.72K | $277.68K | 0.00% | Add |
| Balyasny Asset Management history | Q4 2022 | 44.35K | $213.30K | 0.00% | Reduce |
| Franklin Resources history | Q2 2023 | 56.46K | $211.16K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 34.61K | $160.96K | 0.00% | Add |
| Amundi US history | Q4 2021 | 16.38K | $120.00K | 0.00% | New |
| Janus Henderson Group history | Q1 2023 | 35.91K | $119.76K | 0.00% | Add |
| Norges Bank Investment Management history | Q4 2023 | 36.20K | $110.41K | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 17.70K | $82.30K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 12.18K | $56.64K | 0.00% | Add |
| Principal Global Investors history | Q2 2024 | 11.43K | $37.82K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 7.08K | $32.93K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 2.79K | $12.95K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 115.81K | $539 | 0.00% | Add |
| Lazard Asset Management history | Q3 2023 | 2.30K | $6 | 0.00% | Reduce |